Immunomodulation by the female sex hormones

Open Infectious Diseases Journal

Volumn 3, Issue 1, 2009, Pages 61-72

  Menzies, F M ^a,c   Henriquez, F L ^b  

^a UNIVERSITY OF STRATHCLYDE   (United Kingdom)

^b UNIVERSITY OF THE WEST OF SCOTLAND   (United Kingdom)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84055187824     PISSN: None     EISSN: 18742793     Source Type: Journal    
DOI: 10.2174/1874279300903010061     Document Type: Article

References (167)

1. Makhseed M, Raghupathy R, Azizieh F, Omu A, Al-Shamali E, Ashkanan L. Th1 and Th2 cytokine profiles in recurrent aborters with successful pregnancy and with subsequent abortions. Hum Reprod 2001; 16: 2219-2226.
2. Loke YW, King A. Immunological aspects of human implantation. J Reprod Fertil Suppl 2000; 55: 83-90.
3. Critchley HO, Kelly RW, Brenner RM, Baird DT. The endocrinology of menstruation--a role for the immune system. Clin Endocrinol 2001; 55: 701-710.
4. Chantakru S, Wang WC, van den Heuvel M, et al. Coordinate regulation of lymphocyte-endothelial interactions by pregnancy-associated hormones. J Immunol 2003; 171: 4011-4019.
5. Thongngarm T, Jenkins JK, Ndebele K, McMurray RW. Oestrogen and progesterone modulate monocyte cell cycle progression and apoptosis. Am J Reprod Immunol 2003; 49: 129-138.
6. Chaouat G, Ledee-Bataille N, Zourbas S, et al. Cytokines, implantation and early abortion: re-examining the Th1/Th2 paradigm leads to question the single pathway, single therapy concept. Am J Reprod Immunol 2003; 50: 177-186.
7. Galan A, O'Connor JE, Valbuena D, et al. The human blastocyst regulates endometrial epithelial apoptosis in embryonic adhesion. Biol Reprod 2001; 64: 1283.
8. Salamonsen LA, Nie G, Dimitriadis E, Robb L, Findlay JK. Genes involved in implantation. Reprod Fertil Dev 2001; 13: 41-49.
9. Ma WG, Song H, Das SK, Paria BC, Dey SK. Oestrogen is a critical determinant that specifies the duration of the window of uterine receptivity for implantation. Proc Natl Acad Sci USA 2003; 100: 2963-2968.
10. Castellucci M, Kaufmann P. A three-dimensional study of the normal human placental villus core: II: stromal architecture. Placenta 1982; 3: 269-285.
11. De W, Wood GW. Influence of oestrogen and progesterone on macrophage distribution in the mouse uterus. J Endocrinol 1990; 126: 417-424.
12. Mor G, Abrahams VM. Potential role of macrophages as immunoregulators of pregnancy. Reprod Biol Endocrinol 2003; 1: 119-126.
13. Cupurdija K, Azzola D, Hainz U, et al. Macrophages of human first trimester deciduas express markers associated to alternative activation. Am J Reprod Immunol 2004; 51: 117-122.
14. Vegeto E, Ghisletti S, Meda C, Etteri S, Belcredito S, Maggi A. Regulation of the lipopolysaccharide signal transduction pathway by 17β3-oestradiol in macrophage cells. J Steroid Biochem Mol Biol 2004; 91: 59-66.
15. Roberts CW, Walker W, Alexander J. Sex-associated hormones and immunity to protozoan parasites. Clin Microbiol Rev 2001; 14: 476-488.
16. Deshpande R, Khalili H, Pergolizzi RG, Micael SD, Chang MD. Estradiol down-regulates LPS-induced cytokine production and NF-kB activation in murine macrophages. Am J Reprod Immunol 1997; 38: 46-54.
17. Chao T, Chao H, Chen M, Greager JA, Walter RJ. Female sex hormones modulate the function of LPS-treated macrophages. Am J Reprod Immunol 2000; 44: 310-318.
18. Woodfork KA, Schuller KC, Huffman LJ. Cytokine and nitric oxide release by J774a. 1 macrophages is not regulated by estradiol. Life Sci 2001; 69: 2287-2294.
19. Miller L, Alley EW, Murphy WJ, Russell SW, Hunt JS. Progesterone inhibits inducible nitric oxide synthase gene expression and nitric oxide production in murine macrophages. J Leukoc Biol 1996; 59: 442-450.
20. Robert R, Spitzer JA. Effects of female hormones 17β3-estradiol and progesterone) on nitric oxide production by alveolar macrophages in rats. Nitric Oxide 1997; 1: 453-462.
21. Jones LA, Anthony JP, Henriquez FL, et al. Toll-like receptor-4-mediated macrophage activation is differentially regulated by progesterone via the glucocorticoid and progesterone receptors. Immunology 2008; 125: 59-69.
22. Kämmerer U, Eggert AO, Kapp M, et al. Unique appearance of proliferating antigen-presenting cells expressing DC-SIGN (CD209) in the decidua of early human pregnancy. Am J Pathol 2003; 162: 887-896.
23. Kämmerer U, Schoppet M, McLellan AD, et al. Human deciduas contains potent immunostimulatory CD83+ dendritic cells. Am J Pathol 2000; 157: 159-169.
24. Ivanova E, Kyurkchiev D, Altankova I, Dimitrov J, Binakova E, Kyurkchiev S. CD83+ Monocyte-derived dendritic cells are present in human deciduas and progesterone induces their differentiation in vitro. Am J Reprod Immunol 2005; 53: 199-205.
25. Juretic K, Strbo N, Crncic TB, Laskarin G, Rukavina D. An insight into the dendritic cells at the maternal-fetal interface. AJRI 2004; 52: 350-355.
26. Kangas L, Nieminen AL, Cantell K. Additive and synergistic effects of a novel antiestrogen, toremifene (Fc-1157a), and human interferons on estrogen responsive MCF-7 cells in vitro. Med Biol 1985; 63: 187-190.
27. Paavonen T, Andersson LC. The oestrogen antagonists, tamoxifen and Fc-1157a, display oestrogen like effects on human lymphocyte functions in vitro. Clin Exp Immunol 1985; 61: 467-474.
28. e dendritic cells from bone marrow precursors. J Immunol 2004; 172: 1426-1436.
29. Douin-Echinard V, Laffont S, Seillet C, et al. Estrogen receptor alpha, but not beta, is required for optimal dendritic cell differentiation and CD40-induced cytokine production. J Immunol 2008; 180: 3661-3669.
30. Beagley KW, Gockel CM. Regulation of innate and adaptive immunity by the female sex hormones oestradiol and progesterone. FEMS Immunol Med Microbiol 2003; 38: 13-22.
31. Huck B, Steck T, Habersack M, Dietl J, Kämmerer U. Pregnancy associated hormones modulate the cytokine production but not the phenotype of PBMC-derived human dendritic cells. Eur J Obstet Gynecol 2005; 122: 85-94.
32. Yang L, Liang J, Yao G, Chen P, Hou Y. 17β3-estradiol regulates the numbers, endocytosis, stimulative capacity and IL-10 secretion of mouse spleen dendritic cells. Toxicol Lett 2005; 155: 239-246.
33. b-estradiol on the maturation, nuclear factor kappa B p65 and functions of murine spleen CD11c- positive dendritic cells. Mol Immunol 2006; 43: 357-366.
34. Bengtsson AK, Ryan EJ, Giordano D, Magaletti DM, Clark EA. 17β3-estradiol (E2) modulates cytokine and chemokine expression in human monocyte-derived dendritic cells. Blood 2004; 104: 1404-1410.
35. Ashkar AA, Croy BA. Interferon-y contributes to the normalcy of murine pregnancy. Biol Reprod 1999; 61: 493-502.
36. Croy BA, Ashkar AA, Minhas K, Greenwood JD. Can murine uterine natural killer cells give insights into the pathogenesis of preeclampsia? J Soc Gynecol Invest 2000; 7: 12-20.
37. Ashkar AA, Di Santo JP, Croy BA. Interferon y contributes to initiation of uterine vascular modification, decidual integrity, and uterine natural killer cell maturation during normal murine pregnancy. J Exp Med 2000; 192: 259-269.
38. Redline RW. Role of uterine natural killer cells and interferon y in placental development. J Exp Med 2000; 192: F1-F4.
39. Miller JS. The biology of natural killer cells in cancer, infection and pregnancy. Exp Hematol 2001; 29: 1157-1168.
40. Croy BA, van den Heuvel MJ, Borzychowski AM, Tayade C. Uterine natural killer cells: a specialised differentiation regulated by ovarian hormones. Immunol Rev 2006; 214: 161-185.
41. Higuma-Myojo S, Sasaki Y, Miyazaki S, et al. Cytokine profile of natural killer cells in early human pregnancy. AJRI 2005; 54: 21-29.
42. Dorling A, Monk NJ, Lechler RI. HLA-G inhibits the transendothelial migration of human NK cells. Eur J Immunol 2000; 30: 586-593.
43. Souza SS, Castro FA, Mendonça HC, et al. Influence of menstrual cycle on NK activity. J Reprod Immunol 2001; 50: 151-159.
44. Szekeres-Bartho J, Faust Z, Varga P. The expression of a progesterone-induced immunomodulatory protein in pregnancy lymphocytes. Am J Reprod Immunol 1995; 34: 342-348.
45. Szekeres-Bartho J, Par G, Dombay GY, Smart YC, Volgyi Z. The antiabortive effect of progesterone-induced blocking factor in mice is manifested by modulating NK activity. Cell Immunol 1997; 177: 194-199.
46. Laskarin G, Tokmadzic VS, Strbo N, et al. Progesterone induced Blocking Factor (PIBF) mediates progesterone induced suppression of decidual lymphocyte cytotoxocity. Am J Reprod Immunol 2002; 48: 201-209.
47. Par G, Geli J, Kozma N, Varga P, Szekeres-Bartho J. Progesterone regulates IL-12 expression in pregnancy lymphocytes by inhibiting phospholipase A2. Am J Reprod Immunol 2003; 49: 1-5.
48. de Man YA, Bakker-Jonges LE, Dufour-van den Goorbergh DB, et al. Women with rheumatoid arthritis negative for anti-CCP and rheumatoid factor are more likely to improve during pregnancy, whereas in autoantibody positive women autoantibody levels are not influenced by pregnancy. Ann Rheum Dis 2009 [Epub ahead of print] Available from: http://ard.bmj.com/cgi/rapidpdf/ard.2008.104331v1
49. Doria A, Iaccarino L, Arienti S, et al. Th2 immune deviation induced by pregnancy: the two faces of autoimmune rheumatic disease. Reprod Toxicol 2006; 22: 234-241.
50. Lin H, Mosmann TR, Giobert L, Tuntipopipat S, Wegmann TG. Synthesis of T helper 2-type cytokines at the maternal-fetal interface. J Immunol 1993; 151: 4562-4573.
51. Miyaura H, Iwata M. Direct and indirect inhibition of Th1 development by progesterone and glucocorticoids. J Immunol 2002; 168: 1087-1094.
52. Szekeres-Bartho J, Wegmann TG. A progesterone-dependent immunomodulatory protein alters the Th1/Th2 balance. J Reprod Immunol 1996; 31: 81-95.
53. Szereday L, Varga P, Szekeres-Bartho J. Cytokine production by lymphocytes in pregnancy. Am J Reprod Immunol 1997; 38: 418-422.
54. Kozma N, Halasz M, Polgar B, et al. Progesterone-induced blocking factor activates STAT6 via binding to a novel IL-4 receptor. J Immunol 2006; 176: 819-826.
55. Kozma N, Halasz M, Palkovics T, Szekeres-Bartho J. The progesterone-induced blocking factor modulates the balance of PKC and intracellular Ca++. Am J Reprod Immunol 2006; 55: 122-129.
56. Pernis AB. Estrogen and CD4+ T cells. Curr Opin Rheumatol 2007; 19: 414-420.
57. Klein SL. Hormones and mating system affect sex and species differences in immune function among vertebrates. Behav Proc 2000; 51: 149-166.
58. Fox HS, Bond BL, Parslow TG. Estrogen regulates the IFN-y promoter. J Immunol 1991; 146: 4362-4367.
59. Maret A, Coudert JD, Garidou L, et al. Estradiol enhances primary antigen-specific CD4 T cell responses and Th1 development in vivo: essential role of estrogen receptor alpha expression in hematopoeitic cells. Eur J Immunol 2003; 33: 512-521.
60. Tibbetts TA, DeMayo F, Rich S, Conneely OM, O'Malley BW. Progesterone receptors in the thymus are required for thymic involution during pregnancy and for normal fertility. Proc Natl Acad Sci USA 1999; 96: 12021-12026.
61. Rijhsinghani AG, Thompson K, Bhatia SK, Waldschmidt TJ. Estrogen blocks early T cell development in the thymus. Am J Reprod Immunol 1996; 36: 269-277.
62. high regulatory T cells in human pregnancy. J Reprod Immunol 2005; 65: 111-20.
63. Zenclussen AC. CD4+CD25+ T regulatory cells in murine pregnancy. J Reprod Immunol 2005; 65: 101-110.
64. Hori S, Nomura T, Sakagucji S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003; 299: 1057-1061.
65. Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 2003; 4: 330-336.
66. + regulatory T-cell subset. Immunol 2004; 112: 38-43.
67. Sasaki Y, Sakai M, Miyazaki S, Higuma S, Shiozaki A, Saito S. Decidual and peripheral blood CD4+CD25+ regulatory T cells in early pregnancy subjects and spontaneous abortion cases. Mol Hum Reprod 2004; 10: 347-353.
68. Aluvihare VR, Kallikourdis M, Betz AG. Regulatory T cells mediate maternal tolerance to the fetus. Nat Immunol 2004; 5: 266-271.
69. Zhao J, Zeng Y, Liu Y. Fetal alloantigen is responsible for the expansion of the CD4+CD25+ regulatory T cell pool during pregnancy. J Reprod Immunol 2007; 75: 71-81.
70. Munn DH, Shafizadeh E, Attwood JT, Bondarev I, Pashine A, Mellor AL. Inhibition of T cell proliferation by macrophage tryptophan metabolism. J Exp Med 1999; 189: 1363-1372.
71. Hwu P, Du MX, Lapointe R, Do M, Taylor MW, Young H. Indoleamine 2, 3-dioxygenase production by human dendritic cells results in the inhibition of T cell proliferation. J Immunol 2000; 164: 3596-3599.
72. Munn DH, Zhou M, Attwood JT, et al. Prevention of allogeneic fetal rejection by tryptophan catabolism. Science 1998; 281: 1191-1193.
73. Mellor AL, Munn DH. Tryptophan catabolism and T cell tolerance: immunosuppression by starvation? Immunol Today 1999; 20: 469-473.
74. Grohmann U, Fallerino F, Puccetti P. Tolerance, DCs and tryptophan: much ado about IDO. Trends Immunol 2003; 24: 242-248.
75. Miwa N, Hayakawa S, Miyazaki S, et al. IDO expression on decidual and peripheral blood dendritic cells and monocytes/macrophages after treatment with CTLA-4 or interferon-y increase in normal pregnancy but decrease in spontaneous abortion. Mol Hum Reprod 2005; 11: 865-870.
76. Polanczyk MJ, Hopke C, Huan J, Vandenbark AA, Offner H. Enhanced Foxp3 expression and treg cell function in pregnant and estrogen-treated mice. J Neuroimmunol 2005; 170: 85-92.
77. Prieto GA, Rosenstein Y. Oestradiol potentiates the suppressive function of human CD4+CD25+ regulatory T cells by promoting their proliferation. Immunol 2006; 118: 58-65.
78. Tai P, Wang J, Jin H, et al. Induction of regulatory T cells by physiological level estrogen. J Cell Physiol 2008; 214: 456-464.
79. Medina KL, Strasser A, Kincade PW. Estrogen influences the differentiation, proliferation, and survival of early B-lineage precursors. Blood 2000; 95: 2059-2067.
80. Medina KL, Kincade PW. Pregnancy-related steroids are potential negative regulators of B lymphopoiesis. Proc Natl Acad Sci USA 1994; 91: 5382-5386.
81. Caucheteux SM, Gendron MC, Kanellopoulos-Langevin C. Pregnancy-induced alterations of B cell maturation and survival are differentially affected by Fas and Bcl-2, independently of BcR expression. Int Immunol 2005; 17: 55-63.
82. Yin P, Lin Z, Cheng YH, et al. Progesterone receptor regulates Bcl-2 gene expression through direct binding to its promoter region in uterine myeloma cells. J Clin Endocrinol 2007; 92: 4459-4466.
83. Labeta MO, Margni RA, Leoni J, Binaghi RA. Structure of asymmetric non-precipitating antibody: presence of a carbohydrate residue in only one Fab region of the molecule. Immunol 1986; 57: 311-317.
84. Malan Borel I, Gentile T, Angelucci J, et al. IgG asymmetric molecules with antipaternal activity isolated from sera and placenta of pregnant human. J Reprod Immunol 1991; 20: 129-140.
85. Keleman K, Bognar I, Paal M, Szekeres-Bartho J. A Progesterone-induced protein increases the synthesis of asymmetric antibodies. Cell Immunol 1996; 167: 129-134.
86. Zenclussen AC, Gentile T, Kortebani G, Mazzolli A, Margni R. Asymmetric antibodies and pregnancy. Am J Reprod Immunol 2001; 45: 289-294.
87. Gutierrez G, Gentile T, Miranda S, Margni RA. Asymmetric antibodies: a protective arm in pregnancy. Chem Immunol Allergy 2005; 89: 158-168.
88. Acconcia F, Kumar R. Signaling regulation of genomic and nongenomic functions of estrogen receptors. Cancer Lett 2006; 238: 1-14.
89. Zhang D, Trudeau VL. Integration of membrane and nuclear estrogen receptor signalling. Comp Biochem Physiol 2006; 144: 306-315.
90. Matthews J, Gustafsson JA. Estrogen signaling: a subtle balance between ER-a and ER-β3. Mol Interv 2003; 3: 281-292.
91. Pappas TC, Gametchu B, Watson CS. Membrane estrogen receptors identified by multiple antibody labelling and impededligand binding. FASEB J 1995; 9: 404-410.
92. Campbell CH, Bulayeva N, Brown DB, Gametchu B, Watson CS. Regulation of the membrane estrogen receptor-a: role of cell density, serum, cell passage number, and estradiol. FASEB J 2002; 16: 1917-1927.
93. Phiel KL, Henderson RA, Adelman SJ, Elloso MM. Differential estrogen receptor gene expression in human peripheral blood mononuclear cell populations. Immunol Lett 2005; 97: 107-113.
94. Benten WPM, Lieberherr M, Gise G, Wunderlich F. Estradiol binding to cell surface raises cytosolic free calcium in T cells. FEBS Lett 1998; 422: 349-353.
95. Benten WPM, Stephan C, Wunderlich F. B cells express intracellular but not surface receptors for testosterone and estradiol. Steroids 2002; 67: 647-654.
96. Cutolo M, Accardo S, Villaggio B, et al. Androgen and estrogen receptors are present in primary cultures of human synovial macrophages. J Clin Endocrinol Metab 1996; 81: 820-827.
97. Khan KN, Masuzaki H, Fujishita A, et al. Estrogen and progesterone receptor expression in macrophages and regulation of hepatocyte growth factor by ovarian steroids in women with endometriosis. Hum Reprod 2005; 20: 2004-2013.
98. Kontula K, Paavonen T, Luukkainen T, Andersson LC. Binding of progestins to the glucocorticoid receptor. Biochem Pharmcol 1983; 32: 1511-1518.
99. Wei LL, Horwitz KB. The structure of progesterone receptors. Steroids 1985; 46: 677-695.
100. Tsai MJ, O'Malley BW. Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annu Rev Biochem 1994; 63: 451-486.
101. Jeltsch JM, Turcotte B, Garnier JM, et al. Characterisation of multiple mRNAs originating from the chicken progesterone receptor gene. Evidence for a specific transcript encoding form A. J Biol Chem 1990; 265: 3967-3974.
102. Kastner P, Krust A, Turcotte B, et al. Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B. EMBO J 1990; 9: 1603-1614.
103. Giangrande PH, McDonnell DP. The A and B isoforms of the human progesterone receptor: two functionally different transcription factors encoded by a single gene. Recent Prog Horm Res 1999; 54: 291-313.
104. Uotinen N, Puustinen R, Pasanen S, et al. Distribution of progesterone receptor in female mouse tissues. Gen Comp Endocrinol 1999; 115: 428-441.
105. Flötotto T, Niederacher D, Hohmann T, et al. Molecular mechanism of estrogen receptor (ER)a-specific, estradiol-dependent expression of the progesterone receptor (PR)B-isoform. J Steroid Biochem Mol Biol 2004; 88: 131-142.
106. Leonhardt SA, Boonyaratanakornkit V, Edwards DP. Progesterone receptor transcription and non-transcription signalling mechanisms. Steroids 2003; 68: 761-770.
107. Fernandes MS, Brosens JJ, Gellersen B. Honey, we need to talk about the membrane progestin receptors. Steroids 2008; 73: 942-952
108. King A, Gardner L, Loke YW. Evaluation of oestrogen and progesterone receptors expression in uterine mucosal lymphocytes. Hum Reprod 1996; 11: 1079-1082.
109. Arruvito L, Giulianelli S, Flores AC, et al. NK cells expressing a progesterone receptor are susceptible to progesterone-induced apoptosis. J Immunol 2008; 180: 5746-5753.
110. Dosiou C, Hamilton AE, Pang Y, et al. Expression of membrane progesterone receptors on human T lymphocytes and Jurkat cells and activation of G-proteins by progesterone. J Endocrinol 2008; 196: 67-77.
111. Laurberg P, Bournaud C, Karmisholt J, Orgiazzi J. Management of Graves' hyperthyroidism in pregnancy: focus on both maternal and foetal thyroid function, and caution against surgical thyroidectomy in pregnancy. Eur J Endocrinol 2009; 160: 1-8.
112. Haddow JE, Palomaki GE, Allan WC, et al. Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N Engl J Med 1999; 341: 549-555.
113. Amino N, Tada H, Hidaka Y. Autoimmune thyroid disease and pregnancy. J Endocrinol Invest 1996; 19: 59-70.
114. Azar ST, Tamim H, Beyhum HN, Habbal MZ, Almawi WY. Type I (insulin-dependent) diabetes is a Th1- and Th2-mediated autoimmune disease. Clin Diagn Lab Immunol 1999; 6: 306-310.
115. Alstead EM, Nelson-Piercy C. Inflammatory bowel disease in pregnancy. Gut 2003; 52: 1591-1561.
116. Khosla R, Willoughby CP, Jewell DP. Crohn's disease and pregnancy. Gut 1984; 25: 52-56.
117. Rogers RG, Katz VL. Course of Crohn's disease during pregnancy and its effect on pregnancy outcome: a retrospective review. Am J Perinatol 1995; 12: 262-264.
118. Czymek R, Limmer S, Kleemann M, et al. Crohn's disease-a chameleon during pregnancy. Langenbecks Arch Surg 2009; 394: 517-527.
119. Bortoli A, Saibeni S, Tatarella M, et al. The Study Group for Inflammatory Bowel Diseases GSMII. Pregnancy before and after the diagnosis of inflammatory bowel diseases: retrospective case-control study. J Gastroenterol Hepatol 2007; 22: 542-549.
120. Scher MS. Maternal ulcerative colitis and fetal brain injury: long-term neurologic outcome. J Child Neurol 2007; 22: 1293-1296.
121. Wagner S, Craici I, Reed D, et al. Maternal and foetal outcomes in pregnant patients with active lupus nephritis. Lupus 2009; 18: 342-347.
122. Ostensen M. Sex hormones and pregnancy in rheumatoid arthritis and systemic lupus erythematosus. Ann N Y Acad Sci 1999; 876: 131-143.
123. Khamashta MA, Ruiz-Irastorza G, Hughes GR. Systemic lupus erythematosus flares during pregnancy. Rheum Dis Clin North Am 1997; 23: 15-30.
124. Buyon JP. Neonatal lupus. Curr Opin Rheumatol 1996; 8: 485-490.
125. Lavalle C, Graef A, Baca V, et al. Prolactin and gonadal hormones: a key relationship that may have clinical, monitoring and therapeutic implications in systemic lupus erythematosus. Lupus 1993; 2(2): 71-75.
126. Walker SE, McMurray RW, Houri JM, et al. Effects of prolactin in stimulating disease activity in systemic lupus erythematosus. Ann N Y Acad Sci 1998; 840: 762-772.
127. Whyte A, Williams RO. Bromocriptine suppresses postpartum exacerbation of collagen-induced arthritis. Arthritis Rheum 1988; 31: 927-928.
128. Brennan P, Silman A. Breast-feeding and the onset of rheumatoid arthritis. Arthritis Rheum 1994; 37: 808-813.
129. Lyde CB. Pregnancy in patients with Hansen disease. Arch Dermatol 1997; 133: 623-627.
130. Duncan ME, Pearson JM, Rees RJ. The association of pregnancy and leprosy. II: pregnancy in dapsone-resistant leprosy. Lepr Rev 1981; 52: 263-270.
131. Gellin BG, Broome CV, Bibb WF, Weaver RE, Gaventa S, Mascola L. The epidemiology of listeriosis in the United States-1986. Listeriosis Study Group. Am J Epidemiol 1991; 133: 392-401.
132. Palacios R, Senise J, Vaz M, et al. Short-term antiretroviral therapy to prevent mother-to-child transmission is safe and results in a sustained increase in CD4 T cell counts in HIV-1-infected mothers. HIV Med 2009; 10: 157-162.
133. Neuzil KM, Reed GW, Mitchel EF, et al. Impact of influenza on acute cardiopulmonary hospitalizations in pregnant women. Am J Epidemiol 1998; 148: 1094-1092.
134. Atmar RL, Englund JA, Hammill H. Complications of measles during pregnancy. Clin Infect Dis 1992; 14: 217-226.
135. Avelino MM, Campos D, Jr, do Carmo Barbosa de Parada J, de Castro AM. Pregnancy as a risk factor for acute toxoplasmosis seroconversion. Eur J Obstet Gynecol Reprod Biol 2003; 108: 19-24.
136. Menendez C. Malaria during pregnancy. Curr Mol Med 2006; 6: 269-273.
137. Baeten JM, Lavreys L, Overbaugh J. The influence of hormonal contraceptive use on HIV-1 transmission and disease progression. Clin Infect Dis 2007; 45: 360-369.
138. Leclerc PM, Dubois-Colas N, Garenne M. Hormonal contraception and HIV prevalence in four African countries. Contraception 2008; 77: 371-376.
139. Poonia B, Wang X, Veazey RS. Distribution of simian immunodeficiency virus target cells in vaginal tissues of normal rhesus macaques: implications for virus transmission. J Reprod Immunol 2006; 72: 74-84.
140. Yeaman GR, Howell AL, Weldon S, et al. Human immunodeficiency virus receptor and coreceptor expression on human uterine epithelial cells: regulation of expression during the menstrual cycle and implications for human immunodeficiency virus infection. Immunology 2003; 109: 137-146.
141. Harper SA, Fukuda K, Uyeki TM, et al. Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP). Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2004; 53: 1-40. Erratum in: MMWR Recomm Rep 2004; 53: 743. Update in: MMWR Recomm Rep 2005; 54: 1-40.
142. Roberts CW, Cruickshank SM, Alexander J. Sex-determined resistance to Toxoplasma gondii is associated with temporal differences in cytokine production. Infect Immun 1995; 63: 2549-2555.
143. Menzies FM, Henriquez FL, Roberts CW. Immunological control of congenital toxoplasmosis in the murine model. Immunol Lett 2008; 115: 83-89.
144. Sher A, Oswald IP, Hieny S, Gazzinelli RT. Toxoplasma gondii induces a T-independent IFN-y response in natural killer cells that requires both adherent accessory cells and tumor necrosis factor-a. J Immunol 1993; 150: 3982-3989.
145. Hunter CA, Subauste CS, Van Cleave VH, Remington JS. Production of gamma interferon by natural killer cells from Toxoplasma gondii-infected SCID mice: regulation by interleukin-10, interleukin-12, and tumor necrosis factor alpha. Infect Immun 1994; 62: 2818-2824.
146. Abou-Bacar A, Pfaff AW, Georges S, et al. Role of NK cells and gamma interferon in transplacental passage of Toxoplasma gondii in a mouse model of primary infection. Infect Immun 2004; 72: 1397-1401.
147. Abou-Bacar A, Pfaff AW, Letscher-Bru V, et al. Role of gamma interferon and T cells in congenital Toxoplasma transmission. Parasite Immunol 2004; 26: 315-318.
148. Shiono Y, Mun HS, Nakazaki Y, et al. Maternal-fetal transmission of Toxoplasma gondii in interferon-y deficient mice. Parasitol Int 2007; 56: 141-148.
149. Desai M, Kuil FO, Nosten F, et al. Epidemiology and burden of malaria in pregnancy. Lancet Infect Dis 2007; 7: 93-104.
150. Fried M, Muga RO, Misore AO, Duffy PE. Malaria elicits type I cytokines in the human placenta: IFN-gamma and TNF-alpha associated with pregnancy outcomes. J Immunol 1998; 160: 2523-2530.
151. Schofield L, Grau GE Immunological processes in malaria pathogenesis. Nat Rev Immunol 2005; 5: 722-735.
152. Klein PW, Easterbrook JD, Lalime EN, Klein SL. Estrogen and progesterone affect responses to malaria infection in female C57BL/6 mice. Gend Med 2008; 5: 423-433.
153. Bouyou-Akotet MK, Adegnika AA, Agnandji ST, et al. Cortisol and susceptibility to malaria during pregnancy. Microb Infect 2005; 7: 1217-1223.
154. Krishnan L, Guilbert LJ, Wegmann TG, Belosevic M, Mosmann TR. T helper 1 response against Leishmania major in pregnant C57BL/6 mice increases implantation failure and fetal resorptions. J Immunol 1996; 156: 653-662.
155. Krishnan L, Guilbert LJ, Russell AS, Wegmann TG, Mosmann TR, Belosevic M. Pregnancy impairs resistance of C57BL/6 mice to Leishmania major infection and causes decreased antigen-specific IFN-gamma response and increased production of T helper 2 cytokines. J Immunol 1996; 156: 644-652.
156. Baszler TV, Long MT, McElwain TF, Mathison BA. Interferon-gamma and interleukin-12 mediate protection to acute Neospora caninum infection in BALB/c mice. Int J Parasitol 1999; 29: 1635-1646.
157. Quinn HE, Miller CMD, Ellis JT. The cell-mediated immune response to Neospora caninum during pregnancy in the mouse is associated with a bias towards production of interleukin-4. Int J Parasitol 2004; 34: 723-732.
158. Kano R, Masukata Y, Omata Y, Kobayashi Y, Maeda R, Saito A. Relationship between type1/type2 immune responses and occurrence of vertical transmission in BALB/c mice infected with Neospora caninum. Vet Parasitol 2005; 129: 159-164.
159. Maley SW, Buxton D, Macaldowie CN, et al. Characterisation of the immune response in the placenta of cattle experimentally infected with Neospora caninum in early gestation. J Comp Pathol 2006; 135: 130-141.
160. Klevar S, Kulberg S, Boysen P, et al. Natural killer cells act as early responders in an experimental infection with Neospora caninum in calves. Int J Parsitol 2007; 37: 329-339.
161. Moorman AM, Sullivan AD, Rochford RA, et al. Malaria and pregnancy: placental cytokine expression and its relationship to intrauterine growth retardation. J Infect Dis 1999; 180: 1987-1993.
162. Beeson JG, Duffy PE. The immunology and pathogenesis of malaria during pregnancy. Curr Top Microbiol Immunol 2005; 297: 187-227.
163. Torina A, Caracappa S, Barera A, et al. Toxocara canis infection induces antigen-specific IL-10 and IFNy production in pregnant dogs and their puppies. Vet Immunol Immunopathol 2005; 108: 247-251.
164. Reierova K, Tomasovicova O, Dubinsky P. Influence of maternal infection on offspring immune response in murine larval toxocariasis. Parasite Immunol 2003; 25: 361-368.
165. Hermann E, Truyens C, Alonso-Vega C, et al. Congenital transmission of Trypanosoma cruzi is associated with maternal enhanced parasitaemia and decreased production of interferon-y in response to parasite antigens. J Infect Dis 2004; 189: 1274-1281.
166. Mjihdi A, Lambot MA, Stewart IJ, et al. Acute Trypanosoma cruzi infection in mouse induces infertility of placental parasite invasion and ischemic necrosis associated with massive fetal loss. Am J Pathol 2002; 161: 673-680.
167. Prigione I, Chiesa S, Taverna P, et al. T cell mediated immune responses to Toxoplasma gondii in pregnant women with primary toxoplasmosis. Microbes Infect 2006; 8: 552-560.